Unaudited Condensed Consolidated Statements of Stockholders' Investment - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 29, 2023	Jul. 30, 2022	Jul. 29, 2023	Jul. 30, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ 399,015	$ 306,106	$ 376,231	$ 291,515
Balance - beginning of period (in shares)			27,166,538
Net income	10,902	24,713	$ 46,777	64,060
Issuance of shares through the Company's equity plans	300	369	1,424	907
Purchase of shares under the stock repurchase program	(11,013)	(7,009)	(21,212)	(29,409)
Settlement of net share equity awards			(2,833)	(2,069)
Excise tax on stock repurchases	(103)		(115)
Cash dividends declared	(3,168)	(3,226)	(6,344)	(6,505)
Stock-based compensation	1,377	1,589	3,382	4,044
Balance-end of period	$ 397,310	$ 322,543	$ 397,310	$ 322,543
Balance - end of period (in shares)	27,668,224	27,000,336	27,668,224	27,000,336
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period (in shares)	40,120,000	39,780,000	39,917,000	39,611,000
Balance-beginning of period	$ 401	$ 398	$ 399	$ 396
Issuance of shares through the Company's equity plans (in shares)	12,000	50,000	215,000	219,000
Issuance of shares through the Company's equity plans			$ 2	$ 2
Balance-end of period (in shares)	40,132,000	39,830,000	40,132,000	39,830,000
Balance-end of period	$ 401	$ 398	$ 401	$ 398
Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	216,309	205,720	213,182	202,729
Issuance of shares through the Company's equity plans	300	369	1,422	905
Stock-based compensation	1,377	1,589	3,382	4,044
Balance-end of period	217,986	207,678	217,986	207,678
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	1,170,180	1,058,383	1,137,481	1,022,317
Net income	10,902	24,713	46,777	64,060
Cash dividends declared	(3,168)	(3,226)	(6,344)	(6,505)
Balance-end of period	1,177,914	1,079,872	1,177,914	1,079,872
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ (987,875)	$ (958,395)	$ (974,831)	$ (933,927)
Balance - beginning of period (in shares)	27,373,000	26,855,000	27,167,000	26,318,000
Purchase of shares under the stock repurchase program (in shares)	295,000	145,000	455,000	636,000
Purchase of shares under the stock repurchase program	$ (11,013)	$ (7,009)	$ (21,212)	$ (29,409)
Settlement of net share equity awards (in shares)			47,000	46,000
Settlement of net share equity awards			$ (2,833)	$ (2,069)
Excise tax on stock repurchases	(103)		(115)
Balance-end of period	$ (998,991)	$ (965,405)	$ (998,991)	$ (965,405)
Balance - end of period (in shares)	27,668,000	27,000,000	27,668,000	27,000,000